According to a recent survey supported by HealthyWomen and Palatin Technologies, Inc. [ Editor's note: Palatin Technologies, Inc., is developing bremelanotide, an on-demand treatment for HSDD.], nearly half of premenopausal women (ages 30-50) say they've experienced low sexual desire at some point in their lives, yet only 14 percent were aware that HSDD was a medical condition. HSDD is a form of sexual desire disorder that can be defined as a deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty. This under-reported and under-recognized sexual concern can take a real toll on a woman's romantic relationships and self-esteem.
Low sexual desire is the most common form of female sexual dysfunction (FSD). FSD, the general medical term for disturbance in women's sexual functioning, also includes female sexual arousal disorders, sexual pain disorders and female orgasmic disorder.
Symptoms of low sexual desire include:
- Lack of sexual thoughts
- Lack of sexual desire that cannot be attributed to any other physical or psychiatric condition, nor to any medications
- Distress due to lack of sexual thoughts or desire
- Strain on relationship with partner due to lack of sexual thoughts or desire
If you suffer from one or all of these symptoms, you are not alone. According to the HealthyWomen and Palatin Technologies survey, which included 906 premenopausal women, 46 percent experienced low sexual desire. Of these, about six in 10 were distressed about their dulled cravings for sex.
Why such distress? The survey found that 85 percent of women ages 30 to 50 think low sexual desire hurts the level of intimacy in their romantic relationships. And of these women, 66 percent think low sexual desire negatively impacts their communication with their partners.
But even though low sexual desire is common and significantly affects the lives of women who experience it, no drugs are currently approved for treatment in the United States—a fact that three-quarters of those who identified with the condition in the survey found frustrating. Among those who thought they might have HSDD, nearly all (92 percent) said they would be interested in an HSDD treatment. And as many as 58 percent of women polled indicated they would prefer a treatment that can be taken on-demand or when needed for sexual activity.
Many women are hesitant to talk about their sexuality with their partners or their health care professionals. There is no need to suffer in silence. Problems with sex are common and can often be worked out by educating yourself about the issue and researching professionals who are trained to help. It's also important to be honest with and involve your partner. When the problem is life-disrupting, causes trouble in your relationship or involves physical pain, it's time to talk with your health care professional.